Dive into The Register's online archive of incisive tech news reporting, features, and analysis dating back to 1998 ...

Several analysts were obviously concerned about what they heard during NiCE's latest Capital Markets Day. They reacted by cutting their price targets on the veteran tech company. Those bearish moves ...

Social discomfort is so universal that social psychologists like me have made careers out of studying it. We can find it almost anywhere, like in salary negotiations or small talk conversations that ...

Historically a place where monarchs and aristocrats would escape the winter in favour of warm Mediterranean climes, this southern French city is at its best in the off season. Long before the city’s ...

NICE is a market leader in the contact center-as-a-service field while also advancing operations in financial crime, risk, and compliance, among other fields being transformed by AI. The company’s ...

After Kamala Harris selected Minnesota Gov. Tim Walz as her running mate, much of the media coverage zeroed in on Walz’s Midwestern roots, with some pundits using the phrase “Minnesota nice” to ...

For nearly 20 years, NICE has worked with the National Institute for Health and Care Research (NIHR) to improve the evidence base for new interventions in health and social care. During this period, ...

With new luxury hotels, stylish boutiques, and incredible restaurants, Nice is having a moment. Here's why you should visit this summer. Chrissie McClatchie writes about travel, wine, and yachting ...

Over the past decade—and especially in the years following the pandemic—Marseille has emerged as a port of call for stylish Parisians and creative expats swapping the rigorous demands of urban living ...

Chloe Braithwaite is an Australian writer and editor based in Nice. A weekend in Nice, the French Riviera’s unofficial capital and a magnet for European aristocracy since Queen Victoria’s reign, could ...

The decision follows the conclusion of negotiations between NHS England and the company that sought to agree a commercial arrangement to make Enhertu available at a cost-effective price for the NHS.